Dexcom has issued a Class I recall for its G6 glucose sensor Android application due to a defect that causes the app to crash unexpectedly. As a result of the app terminating, users could miss ...
Rising costs and complex care make diabetes a daily challenge. Local patient and pharmacy expert share strategies, struggles, ...
American Diversified Holdings Corporation (OTCID: ADHC) announced today that GlucoGuard has completed the Level 2 App integration ...
The global Blood Glucose Monitoring System Market, valued at US$15.16 billion in 2024, stood at US$16.46 billion in 2025 and ...
Now, it’s worth noting Stock Advisor's total average return is 1,064% — a market-crushing outperformance compared to 194% for ...
Recently, multiple class action lawsuits were filed against DexCom, Inc. after reports surfaced alleging the company made unauthorized design changes to its G6 and G7 continuous glucose monitoring ...
What Is The Lawsuit About? The lawsuit has been filed on behalf of investors who purchased securities during the period of July 26, 2024 through September 17, 2025, inclusive ("the Class Period"). The ...
The global Blood Glucose Monitoring System Market, valued at US$15.16 billion in 2024, stood at US$16.46 billion in 2025 and is projected to ...
Detailed price information for Tandem Diabetes Care (TNDM-Q) from The Globe and Mail including charting and trades.
The Motley Fool on MSN
Should You Buy DexCom Stock Before Oct. 31?
Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.
Investor's Business Daily on MSN
The Wild Ride That Sent IBD Stock Of The Day Insulet Into An Early Breakout
Insulet is Thursday's IBD Stock Of The Day. After a wild post-earnings reaction, Insulet stock is in a consolidation with an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback